(Q50571700)

15 March 2018

title

Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease. (English)

1 reference

15 March 2018

1 reference

1 reference

1 reference

1 reference

1 reference

Manal F Abdelmalek

1

1 reference

15 March 2018

Chen Liu

series ordinal

2

1 reference

15 March 2018

John F Valentine

series ordinal

3

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

15 March 2018

The American Journal of Gastroenterology

published in

1 reference

15 March 2018

volume

102

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

page(s)

1333-1334

1 reference

15 March 2018

Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01131.X

Biomedicines to reduce inflammation but not viral load in chronic HCV--what's the sense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01131.X

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01131.X

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01131.X

10.1111/J.1572-0241.2007.01131.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

17531027

1 reference

15 March 2018